New combo therapy offers hope for cancer patients who Can't breathe
NCT ID NCT06306638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a two-step treatment for people with advanced cancer that blocks their airways. First, they get low-dose radiation to shrink the tumor. Then, they receive a light-activated drug through an IV, followed by a laser to destroy remaining tumor cells. The goal is to improve breathing and survival with fewer side effects than high-dose radiation alone. About 42 adults with inoperable tumors will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer reveal hidden immune clues in tumors?
- A hug in a blanket: could deep pressure calm cancer infusion anxiety?
- A virtual pharmacy visit may ease opioid fears for cancer patients
- Can meditation tame the Long-Term side effects of a stem cell transplant?
- Strumming through treatment: can ukulele lessons shield teen brains from Radiation's toll?
- A smartphone app may help young cancer survivors get fitter — a trial puts it to the test